Replies to post #250 on Ariad Pharmaceuticals Inc fka ARIA

[glass_half_full]

[a]lthough the recent pps sure doesn't seem to be reflecting that at the moment

Agreed -- but technically, we could put in a bit of a hammer today right at the lows of March 18. It would be a nice spot for a turn-around. (OK, anywhere would be a nice spot....)

[DonShimoda]

I just reviewed the Tasigna approval time-line and it looks like their Phase 3 trial started in March 2006. The trial was stopped early and accelerated approval was granted in Oct 2007, basically 18 months from first enrollment. http://www.clinicaltrials.gov/ct2/show/NCT00302016?term=Nilotinib&rank=49

fyi, the primary endpoint was a 40% MCyR in chronic phase patients. http://www.cancer.gov/cancertopics/druginfo/fda-nilotinib